Irgm1−/− mice display susceptibility to intestinal inflammation in multiple contexts (42, –, 44), increased cytokine production upon LPS treatment (45, 46), and type I interferonopathy resembling Sjogren’s syndrome (47), paralleling several human disease syndromes associated with IRGM variants. This evidence concerns the gene IRGM and Sjogren syndrome.